Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GHRP-3 Infusion in Insulin Resistance
NCT00846872Phase 2Withdrawn
- Sponsor
- Tulane University
- Start
- Jul 2008
- Primary completion
- Mar 2012
- Modality
- Peptides
01
Overview
A Phase 2 trial of human growth hormone-releasing peptide 3 in insulin resistance (IR), endothelial dysfunction, sponsored by Tulane University. Planned start Jul 2008; status: withdrawn.
02
Drugs
human growth hormone-releasing peptide 3
03
Conditions
insulin resistance (IR)endothelial dysfunction
Beyond the preview
Go deeper on NCT00846872.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00846872.